Early-stage non-small cell lung cancer (NSCLC) is on the rise due to the implementation of
screening guidelines for patients at risk for developing lung cancer. It is anticipated that as …

Background The optimal treatment of stage I non–small-cell lung carcinoma is subject to
debate. The aim of this study was to compare overall survival and oncologic outcomes of …

Cancer is the leading cause of death in older adults aged 60 to 79 years. Older patients with
good performance status are able to tolerate commonly used treatment modalities as well as …

Objective Stereotactic body radiotherapy (SBRT) for early-stage non-small-cell lung cancer
(NSCLC) is the standard of care in medically inoperable patients. In very elderly patients …

Objectives It is unclear whether elderly patients face an increased risk of complications
following stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung …

Simple Summary Surgery is the standard treatment for stage I non-small-cell lung cancer
(NSCLC), but is often difficult to perform in elderly patients due to their comorbidities and …

Background Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC)
is primarily a treatment option for medically inoperable patients, who are often elderly …

Introduction Microwave ablation (MWA) is a relatively new minimally invasive treatment
option for lung cancer with substantially lower morbidity and mortality than surgery. This …

Background To compare the clinical outcomes of patients with early-stage non–small-cell
lung cancer (NSCLC) who had undergone either single-fraction (SF) or three-fraction (TF) …

Objectives Insights regarding utilization and survival of surgery and radiotherapy
(stereotactic body radiotherapy (SBRT) or conventional radiotherapy (RT)) are lacking for …